Early research (Phase 1)Study completedNCT05009199What this trial is testingOccupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444Who this might be right forHealthy Volunteer Invicro 3
Not applicableEnded earlyNCT05349019What this trial is testingA Natural History Study of Patients With G2019S LRRK2 Parkinson's DiseaseWho this might be right forPatients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene Escape Bio, Inc. 22
Not applicableStudy completedNCT01085227What this trial is testingClinical, Molecular and by Neuroimaging of LRRK2 MutationsWho this might be right forParkinson's Disease Institut National de la Santé Et de la Recherche Médicale, France 50
Not applicableEnded earlyNCT00467090What this trial is testingCharacteristics of Parkinson s Disease Associated With the LRRK-2 Gene MutationWho this might be right forParkinson Disease National Institute of Neurological Disorders and Stroke (NINDS) 34
Not applicableUnknownNCT01730599What this trial is testingA Longitudinal Study in Parkinson's Disease (PD) PatientsWho this might be right forParkinson's Disease Tel-Aviv Sourasky Medical Center 200
Not applicableUnknownNCT04387812What this trial is testingEvaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's DiseaseWho this might be right forParkinson DiseaseGBA Gene MutationLeucine-rich Repeat Kinase 2 (LRRK2) Gene Mutation Tel-Aviv Sourasky Medical Center 240